Linking atrial fibrillation with Alzheimer’s disease: epidemiological, pathological, and mechanistic evidence

Lecture fees from Boehringer Ingelheim, Mitsubishi Tanabe Pharma, Otsuka Pharmaceutical, Takeda Pharmaceutical Company, Astellas Pharma, Daiichi Sankyo Company, and Eisai. The amount is less than 10,000 USD/year from each company.